Skip to main content
Richard Lafayette, MD, Nephrology, Palo Alto, CA

RichardAlanLafayetteMD

Nephrology Palo Alto, CA

Professor, Medicine - Nephrology, Stanford University Medical Center

Dr. Lafayette is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lafayette's full profile

Already have an account?

  • Office

    300 Pasteur Dr
    Palo Alto, CA 94305
    Phone+1 650-725-6186
    Fax+1 650-725-8418

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Nephrology, 1988 - 1991
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1985 - 1987
  • New York Medical College
    New York Medical CollegeClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2025
  • MA State Medical License
    MA State Medical License 1992 - 1996
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Cause of Kidney Disease and Cardiovascular Events in a National Cohort of US Patients with End-Stage Renal Disease on Dialysis: A Retrospective Analysis  
    Wolfgang C Winkelmayer, Richard A Lafayette, European Heart Journal

Abstracts/Posters

  • Facing the Vexing Problem of Recurrent FSGS After Kidney Transplantation
    Richard Lafayette, MD, American Society of Nephrology, Orlando, FL, 12/7/2019
  • Facing the Vexing Problem of Recurrent FSGS After Kidney Transplantation
    Richard Lafayette, MD, American Society of Nephrology, Orlando, FL, 12/7/2019

Press Mentions

  • Calliditas Announces Late-Breaking Presentations at the 60th European Renal Association (ERA) Congress 2023
    Calliditas Announces Late-Breaking Presentations at the 60th European Renal Association (ERA) Congress 2023May 5th, 2023
  • Omeros Announces Results from Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy Trial
    Omeros Announces Results from Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy TrialNovember 5th, 2021
  • Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephropathy
    Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA NephropathySeptember 9th, 2021
  • Join now to see all

Grant Support

  • Oral Calcimimetic Agent In Secondary HyperparathyroidismNational Center For Research Resources2000–2001